Up­dat­ed: In new speed bump for Hunt­ing­ton's, FDA paus­es PTC's PhII tri­al

PTC Ther­a­peu­tics has run in­to a road­block for its Hunt­ing­ton’s dis­ease pro­gram as the FDA flash­es the red light on a Phase II study. …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.